Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Black Diamond Therapeutics (BDTX)

  • Event
  • Aug. 09, 2022, 00:00 UTC
  • 75
  • 1 comments

(28% Negative) BLACK DIAMOND THERAPEUTICS, INC. (BDTX) Reports 33% Loss Increase for 2022-06-30

Comment Full text

Beam Therapeutics Inc (BEAM)

  • Event
  • Aug. 09, 2022, 00:00 UTC
  • 32
  • 1 comments

(42% Neutral) Beam Therapeutics Inc. (BEAM) Reports Net Loss for 2022-06-30

Comment Full text

Cogent Biosciences Inc (COGT)

  • Event
  • Aug. 09, 2022, 00:00 UTC
  • 31
  • 1 comments

(75% Positive) Cogent Biosciences, Inc. (COGT) Reports 57% Loss Reduction for 2022-06-30

Comment Full text

Amphastar (AMPH)

  • Event
  • Aug. 08, 2022, 20:23 UTC
  • 37
  • 1 comments

(79% Neutral) Amphastar Pharmaceuticals, Inc. (AMPH) Reports Q3 2022 Financial Results

Comment Full text

Terns Pharmaceuticals Inc (TERN)

  • Event
  • Aug. 08, 2022, 20:19 UTC
  • 37
  • 1 comments

(30% Negative) Terns Pharmaceuticals, Inc. (TERN) Reports Q3 2022 Financial Results

Comment Full text

Inhibrx (INBX)

  • Event
  • Aug. 08, 2022, 20:19 UTC
  • 32
  • 1 comments

(30% Negative) INHIBRX, INC. (INBX) Reports Q3 2022 Financial Results

Comment Full text

Castle Biosciences Inc (CSTL)

  • Event
  • Aug. 08, 2022, 14:00 UTC
  • 112
  • 0 comments

Castle Biosciences - Castle Biosciences 2022 Investor Day

Comment Full text

Cyteir Therapeutics (CYT)

  • Event
  • Aug. 08, 2022, 13:20 UTC
  • 116
  • 0 comments

Cyteir Therapeutics - Corporate Presentation August 2022

Comment Full text

Guardant Health Inc. (GH)

  • Event
  • Aug. 08, 2022, 13:07 UTC
  • 106
  • 0 comments

Guardant Health, Inc. - UBS Genomics 2.0 and MedTech Innovations Summit Conference

Comment Full text

Castle Biosciences Inc (CSTL)

  • Event
  • Aug. 08, 2022, 13:07 UTC
  • 112
  • 0 comments

Castle Biosciences - Corporate Presentation

Comment Full text
  • Previous
  • 522
  • 523
  • 524
  • 525
  • 526
  • Next

Search

News categories

  • Technical Exchange News(12472)
  • Event(6229)
  • SEC News(281170)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(161223)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin